Cairo – Mubasher: The extraordinary general meeting (EGM) of Ibnsina Pharma has approved an increase in the company's issued capital to EGP 280 million from EGP 240 million through the issuance of bonus shares.

The company's issued capital is distributed over 1.12 million shares at a nominal value of EGP 0.25 per share, according to a bourse filing on Sunday. 

It is noteworthy to mention that in the first nine months of 2021, the company achieved consolidated net profits of EGP 241.94 million, up by 20.6% year-on-year (YoY) from EGP 200.61 million, including minority shareholders' rights.